# A Phase 1, Open-label, Multicenter, Safety and Pharmacokinetic Study of EDI200

> **NCT01564225** · PHASE1 · COMPLETED · sponsor: **Edimer Pharmaceuticals** · enrollment: 6 (actual)

## Conditions studied

- X-linked Hypohidrotic Ectodermal Dysplasia

## Interventions

- **DRUG:** EDI200

## Key facts

- **NCT ID:** NCT01564225
- **Lead sponsor:** Edimer Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2013-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01564225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01564225, "A Phase 1, Open-label, Multicenter, Safety and Pharmacokinetic Study of EDI200". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01564225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*